<rss version="2.0"><channel><title>Yahoo! Finance: VRX.TO News</title><copyright>Copyright (c) 2017 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=vrx.to</link><description>Latest Financial News for VALEANT PHARMACEUTICALS INTL IN</description><language>en-US</language><lastBuildDate>Thu, 26 Jan 2017 12:00:12 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: VRX.TO News</title><link>http://finance.yahoo.com/q/h?s=vrx.to</link><width>144</width><height>45</height></image><item><title>Bear of the Day: Valeant Pharmaceuticals (VRX)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-120012015.html</link><description /><guid isPermaLink="false">yahoo_finance/395233618</guid><pubDate>Thu, 26 Jan 2017 12:00:12 GMT</pubDate></item><item><title>Analysts dismiss Citron's sour take on TransDigm</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=132thmf0q/*https://www.thestreet.com/story/13962492/1/analysts-dismiss-citron-s-sour-take-on-transdigm.html?puc=yahoo&amp;cm_ven=YAHOO</link><description /><guid isPermaLink="false">yahoo_finance/2584452764</guid><pubDate>Mon, 23 Jan 2017 19:45:00 GMT</pubDate></item><item><title>What Will Valeant Pharmaceuticals Sell Off Next?</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12vghk0gb/*http://www.fool.com/investing/2017/01/20/what-will-valeant-pharmaceuticals-sell-off-next.aspx?source=yahoo-2&amp;utm_campaign=article&amp;utm_medium=feed&amp;utm_source=yahoo-2</link><description /><guid isPermaLink="false">yahoo_finance/4147366576</guid><pubDate>Sat, 21 Jan 2017 19:42:39 GMT</pubDate></item><item><title>Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13oldae8l/*https://www.thestreet.com/story/13960921/1/short-seller-andrew-left-says-trump-should-target-this-aerospace-stock.html?puc=yahoo&amp;cm_ven=YAHOO</link><description /><guid isPermaLink="false">yahoo_finance/1761490894</guid><pubDate>Fri, 20 Jan 2017 20:31:00 GMT</pubDate></item><item><title>Research Reports Initiated on Healthcare Stocks Knight Therapeutics, Valeant Pharmaceuticals International, Merus Labs International, and Canopy Growth</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/research-reports-initiated-healthcare-stocks-131500859.html</link><description /><guid isPermaLink="false">yahoo_finance/1535801118</guid><pubDate>Wed, 18 Jan 2017 13:15:00 GMT</pubDate></item><item><title>[$$] Allergan Admits to Disclosure Violations During Valeant Bid</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=134pe5ubv/*http://www.wsj.com/articles/allergan-admits-to-disclosure-violations-during-valeant-bid-1484693391?mod=yahoo_hs</link><description /><guid isPermaLink="false">yahoo_finance/3328578897</guid><pubDate>Tue, 17 Jan 2017 22:49:55 GMT</pubDate></item><item><title>Valeant Pharmaceuticals International, Inc. &#8211; Value Analysis (TORONTO:VRX) : January 13, 2017</title><link>http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=1404b3rg2/*http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-torontovrx-january-13-2017/</link><description /><guid isPermaLink="false">yahoo_finance/1880057905</guid><pubDate>Fri, 13 Jan 2017 16:14:10 GMT</pubDate></item><item><title>Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/pharma-stock-roundup-trump-targets-110211779.html</link><description /><guid isPermaLink="false">yahoo_finance/2225939446</guid><pubDate>Fri, 13 Jan 2017 11:02:11 GMT</pubDate></item><item><title>Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?</title><link>http://us.rd.yahoo.com/finance/external/xinsidermonkey/rss/SIG=13cpsgp5t/*http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-stock-back-from-the-dead-517117/</link><description /><guid isPermaLink="false">yahoo_finance/3016185222</guid><pubDate>Thu, 12 Jan 2017 16:33:08 GMT</pubDate></item><item><title>Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-CA : January 12, 2017</title><link>http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=1545h7f72/*http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-ca-january-12-2017/</link><description /><guid isPermaLink="false">yahoo_finance/3695818182</guid><pubDate>Thu, 12 Jan 2017 13:11:16 GMT</pubDate></item><item><title>Valeant Pharmaceuticals: Separating Fact From Fiction</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13234jmnp/*http://www.fool.com/investing/2017/01/11/valeant-pharmaceuticals-separating-fact-from-ficti.aspx?source=yahoo-2&amp;utm_campaign=article&amp;utm_medium=feed&amp;utm_source=yahoo-2</link><description /><guid isPermaLink="false">yahoo_finance/2710549850</guid><pubDate>Wed, 11 Jan 2017 21:54:07 GMT</pubDate></item><item><title>Valeant Streamlines Portfolio with Skincare Brands Sale</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html</link><description /><guid isPermaLink="false">yahoo_finance/891544681</guid><pubDate>Wed, 11 Jan 2017 21:42:09 GMT</pubDate></item><item><title>Wednesday&#8217;s Top Biopharma Movers</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/wednesday-top-biopharma-movers-202217751.html</link><description /><guid isPermaLink="false">yahoo_finance/2378193529</guid><pubDate>Wed, 11 Jan 2017 20:22:17 GMT</pubDate></item><item><title>Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12bv313fd/*https://www.thestreet.com/story/13949672/1/quot-the-new-valeant-quot.html?puc=yahoo&amp;cm_ven=YAHOO</link><description /><guid isPermaLink="false">yahoo_finance/2545157745</guid><pubDate>Wed, 11 Jan 2017 19:51:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals: Now Comes the Hard Part</title><link>http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=139o0kbh2/*http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-now-comes-the-hard-part/?mod=yahoobarrons&amp;ru=yahoo</link><description /><guid isPermaLink="false">yahoo_finance/1552936574</guid><pubDate>Wed, 11 Jan 2017 17:40:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals: 'A Long Road to Recovery'</title><link>http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=1394cjcbo/*http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-a-long-road-to-recovery/?mod=yahoobarrons&amp;ru=yahoo</link><description /><guid isPermaLink="false">yahoo_finance/303574570</guid><pubDate>Wed, 11 Jan 2017 15:15:00 GMT</pubDate></item><item><title>Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/options-traders-know-something-valeant-134001277.html</link><description /><guid isPermaLink="false">yahoo_finance/278836297</guid><pubDate>Wed, 11 Jan 2017 13:40:01 GMT</pubDate></item><item><title>This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1312irk06/*http://www.fool.com/investing/2017/01/11/this-is-the-smartest-move-valeant-pharmaceuticals.aspx?source=yahoo-2&amp;utm_campaign=article&amp;utm_medium=feed&amp;utm_source=yahoo-2</link><description /><guid isPermaLink="false">yahoo_finance/3536904684</guid><pubDate>Wed, 11 Jan 2017 12:41:07 GMT</pubDate></item><item><title>PRESS DIGEST - Wall Street Journal - Jan 11</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/press-digest-wall-street-journal-052059617.html</link><description>[Reuters] - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Volkswagen AG is expected to agree to plead guilty to criminal ...</description><guid isPermaLink="false">yahoo_finance/3517770155</guid><pubDate>Wed, 11 Jan 2017 05:20:59 GMT</pubDate></item><item><title>[$$] L&#8217;Or&#233;al Looks to Gain U.S. Share by Buying Valeant Brands</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=130qsje8b/*http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?ru=yahoo?mod=yahoo_itp</link><description /><guid isPermaLink="false">yahoo_finance/344972899</guid><pubDate>Wed, 11 Jan 2017 05:07:46 GMT</pubDate></item><item><title>[$$] Valeant Strikes Deals to Shed $2.1 Billion in Assets</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ia10d1s/*http://www.wsj.com/articles/valeant-to-sell-skincare-brands-to-loreal-1484038804?ru=yahoo?mod=yahoo_itp</link><description /><guid isPermaLink="false">yahoo_finance/4098379993</guid><pubDate>Wed, 11 Jan 2017 03:53:48 GMT</pubDate></item><item><title>Nasdaq closes at 4th straight record&#8212;marks best such streak since 1999</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11iiumket/*http://www.marketwatch.com/News/Story/Story.aspx?guid=4ADF798A-D70D-11E6-B2D1-5BB37AF8AA48&amp;siteid=yhoof2</link><description /><guid isPermaLink="false">yahoo_finance/1047712492</guid><pubDate>Tue, 10 Jan 2017 21:55:51 GMT</pubDate></item><item><title>Valeant to sell assets for $2.12 billion to ease debt load</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/loreal-buy-three-skincare-brands-074743675.html</link><description /><guid isPermaLink="false">yahoo_finance/204990475</guid><pubDate>Tue, 10 Jan 2017 18:46:51 GMT</pubDate></item><item><title>Valeant sells $2B in assets to begin paying down debt</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652771.html</link><description /><guid isPermaLink="false">yahoo_finance/913276643</guid><pubDate>Tue, 10 Jan 2017 12:59:02 GMT</pubDate></item><item><title>Valeant to sell Dendreon unit to China's Sanpower for $820 million</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309937.html</link><description /><guid isPermaLink="false">yahoo_finance/1431458154</guid><pubDate>Tue, 10 Jan 2017 04:47:04 GMT</pubDate></item><item><title>Valeant to sell Dendreon unit to China's Sanpower for $819.9 million</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309681.html</link><description /><guid isPermaLink="false">yahoo_finance/1319578094</guid><pubDate>Tue, 10 Jan 2017 04:03:09 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12855fpoa/*http://www.publicnow.com/view/E9685D2F9C18729A8ADFD8A7FBAEA3758C74C3F2</link><description>[at noodls] - LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter ...</description><guid isPermaLink="false">yahoo_finance/3654041654</guid><pubDate>Wed, 04 Jan 2017 21:33:12 GMT</pubDate></item><item><title>Senators urge action to block drastic drug price hikes</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/senators-urge-action-block-drastic-203402211.html</link><description /><guid isPermaLink="false">yahoo_finance/1444997883</guid><pubDate>Wed, 21 Dec 2016 22:01:14 GMT</pubDate></item><item><title>Takeda's talks to acquire Valeant's Salix stall - sources</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173642704.html</link><description /><guid isPermaLink="false">yahoo_finance/3470303934</guid><pubDate>Wed, 30 Nov 2016 17:36:42 GMT</pubDate></item><item><title>Valeant shares sink as company warns of rocky year ahead</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957997.html</link><description /><guid isPermaLink="false">yahoo_finance/4268537672</guid><pubDate>Tue, 08 Nov 2016 20:03:36 GMT</pubDate></item><item><title>Valeant shares sink as company warns of rocky year ahead</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957325.html</link><description /><guid isPermaLink="false">yahoo_finance/1830503760</guid><pubDate>Tue, 08 Nov 2016 20:03:36 GMT</pubDate></item><item><title>Valeant Reports Third Quarter 2016 Financial Results</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128jtvsom/*http://www.publicnow.com/view/36E4665575CA23CC2E7AA445714F00CEFE6B906F</link><description>[at noodls] - - Total Revenues of $2.48 billion - GAAP Cash Flow from Operations of $570 million - GAAP EPS of ($3.49) and Adjusted EPS (non-GAAP) of $1.55 - Revising 2016 Full Year Guidance LAVAL, Quebec, Nov. 8, 2016 ...</description><guid isPermaLink="false">yahoo_finance/857334403</guid><pubDate>Tue, 08 Nov 2016 11:36:14 GMT</pubDate></item><item><title>Valeant sued for botching marketing of female libido pill</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-ex-sprout-investors-180908308.html</link><description /><guid isPermaLink="false">yahoo_finance/2049291807</guid><pubDate>Wed, 02 Nov 2016 21:12:33 GMT</pubDate></item><item><title>Japan's Takeda shares halted on news of interest in Valeant assets</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/japans-takeda-shares-halted-news-001946012.html</link><description /><guid isPermaLink="false">yahoo_finance/1874026756</guid><pubDate>Wed, 02 Nov 2016 00:21:26 GMT</pubDate></item><item><title>Valeant says in talks to sell Salix stomach-drug business</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-talks-sell-salix-stomach-202100544.html</link><description /><guid isPermaLink="false">yahoo_finance/290573609</guid><pubDate>Tue, 01 Nov 2016 22:56:38 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Comments On Press Report Regarding Its Gastroenterology Business Unit</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128hl3kd9/*http://www.publicnow.com/view/B4F1490F51663A53D43A88FC86A61CC9BCA47EFD</link><description>[at noodls] - LAVAL, Quebec, Nov. 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ...</description><guid isPermaLink="false">yahoo_finance/4110588143</guid><pubDate>Tue, 01 Nov 2016 21:40:08 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Comments On Press Report</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1285bhotb/*http://www.publicnow.com/view/7624F2727F53773DA4D05F817B47123086BE4440</link><description>[at noodls] - LAVAL, Quebec, Oct. 31, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ...</description><guid isPermaLink="false">yahoo_finance/2934532370</guid><pubDate>Mon, 31 Oct 2016 20:53:11 GMT</pubDate></item><item><title>Valeant Announces Third Quarter Financial Results Date And Conference Call Details</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1280fb3om/*http://www.publicnow.com/view/741280190E9B938D3DE220A4E6DFCD060763273B</link><description>[at noodls] - LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, ...</description><guid isPermaLink="false">yahoo_finance/682756898</guid><pubDate>Mon, 17 Oct 2016 16:23:06 GMT</pubDate></item><item><title>Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128h8rcmr/*http://www.publicnow.com/view/6370ED49C0B3354F063CCD3A60A584C278012D62</link><description>[at noodls] - LAVAL, Quebec, Oct. 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Patient Access and Pricing Committee (the 'Committee') ...</description><guid isPermaLink="false">yahoo_finance/4242533706</guid><pubDate>Fri, 14 Oct 2016 17:11:02 GMT</pubDate></item><item><title>Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128g3dtjb/*http://www.publicnow.com/view/F533724D904956CC71224CD857F06C9A3A79DF50</link><description>[at noodls] - LAVAL, Quebec, Sept. 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') seeks to clarify statements made in a media report today. Pursuant ...</description><guid isPermaLink="false">yahoo_finance/2951821368</guid><pubDate>Fri, 16 Sep 2016 20:38:08 GMT</pubDate></item><item><title>Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor&#174; Tablets</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12844mtad/*http://www.publicnow.com/view/91B608427A9370F9E9D4A8BE1B515FBBF86761E2</link><description>[at noodls] - LAVAL, Quebec, Sept. 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) ('Progenics') today announced ...</description><guid isPermaLink="false">yahoo_finance/1230006237</guid><pubDate>Tue, 06 Sep 2016 21:09:05 GMT</pubDate></item><item><title>Valeant is sued over Philidor ties, alleged racketeering</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532942.html</link><description /><guid isPermaLink="false">yahoo_finance/48930079</guid><pubDate>Mon, 29 Aug 2016 19:39:35 GMT</pubDate></item><item><title>Valeant is sued over Philidor ties, alleged racketeering</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532626.html</link><description /><guid isPermaLink="false">yahoo_finance/3702238115</guid><pubDate>Mon, 29 Aug 2016 19:39:35 GMT</pubDate></item><item><title>Valeant is sued over Philidor ties, alleged racketeering</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-182904100.html</link><description /><guid isPermaLink="false">yahoo_finance/1287879708</guid><pubDate>Mon, 29 Aug 2016 19:36:58 GMT</pubDate></item><item><title>Valeant hires Zoetis's Paul Herendeen as CFO</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-hires-zoetiss-paul-herendeen-111217790.html</link><description /><guid isPermaLink="false">yahoo_finance/156222253</guid><pubDate>Mon, 22 Aug 2016 11:12:17 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128bkijlu/*http://www.publicnow.com/view/CA8FDDADEC0D083FE5244ED05B7D3A65F4186F72</link><description>[at noodls] - Robert L. Rosiello to Remain at Valeant as Executive Vice President, Corporate Development and Strategy LAVAL, Quebec, Aug. 22, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ...</description><guid isPermaLink="false">yahoo_finance/2711949557</guid><pubDate>Mon, 22 Aug 2016 10:18:07 GMT</pubDate></item><item><title>Valeant expected to announce Herendeen as new CFO - WSJ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-expected-announce-herendeen-cfo-004426829.html</link><description /><guid isPermaLink="false">yahoo_finance/3024889780</guid><pubDate>Mon, 22 Aug 2016 00:44:26 GMT</pubDate></item><item><title>LPC: Valeant lenders agree to loan amendment to loosen covenants</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-lenders-agree-loan-131713796.html</link><description /><guid isPermaLink="false">yahoo_finance/1155987382</guid><pubDate>Thu, 18 Aug 2016 13:17:13 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128j4tk05/*http://www.publicnow.com/view/F9A95680881CD97A07DF364826AE4804FA8B4A07</link><description>[at noodls] - LAVAL, Quebec, Aug. 18, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') today announced that it has obtained the requisite lender approval ...</description><guid isPermaLink="false">yahoo_finance/385442056</guid><pubDate>Thu, 18 Aug 2016 12:21:09 GMT</pubDate></item><item><title>Valeant stock falls as report of criminal probe adds to woes</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-stock-falls-report-criminal-130059625.html</link><description /><guid isPermaLink="false">yahoo_finance/3039466630</guid><pubDate>Thu, 11 Aug 2016 19:37:34 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Comments On SDNY Investigation</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128sqht2e/*http://www.publicnow.com/view/A5A9D62E6E14FE486936F96E198FB6528DED47B4</link><description>[at noodls] - LAVAL, Quebec, Aug. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding the ongoing investigation being ...</description><guid isPermaLink="false">yahoo_finance/2883518204</guid><pubDate>Thu, 11 Aug 2016 03:01:20 GMT</pubDate></item><item><title>Valeant under criminal investigation over Philidor ties - WSJ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-over-012018663.html</link><description /><guid isPermaLink="false">yahoo_finance/3927211633</guid><pubDate>Thu, 11 Aug 2016 01:20:18 GMT</pubDate></item><item><title>Valeant under criminal investigation - WSJ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653215.html</link><description /><guid isPermaLink="false">yahoo_finance/2231775321</guid><pubDate>Wed, 10 Aug 2016 23:32:37 GMT</pubDate></item><item><title>Valeant under criminal investigation - WSJ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653606.html</link><description /><guid isPermaLink="false">yahoo_finance/3015511416</guid><pubDate>Wed, 10 Aug 2016 23:32:37 GMT</pubDate></item><item><title>LPC: Valeant loans rise after CEO says company to seek debt amendment</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-loans-rise-ceo-201130398.html</link><description /><guid isPermaLink="false">yahoo_finance/3646813985</guid><pubDate>Tue, 09 Aug 2016 20:11:30 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286o36fa/*http://www.publicnow.com/view/220D7A4E104294546F66D6981108546BFE140148</link><description>[at noodls] - 2016 Full Year Guidance Reconfirmed LAVAL, Quebec, Aug. 9, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, a decrease of 11% versus the second quarter of 2015 GAAP EPS ($0.88) and Adjusted EPS (non-GAAP) ...</description><guid isPermaLink="false">yahoo_finance/628671418</guid><pubDate>Tue, 09 Aug 2016 10:10:08 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128b3bc12/*http://www.publicnow.com/view/3E2B92B2573830CCB56B85E274AFEF6F1EA4A7F7</link><description>[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the relaunch of its generic ofloxacin otic solution to treat bacterial ear ...</description><guid isPermaLink="false">yahoo_finance/1995700050</guid><pubDate>Mon, 08 Aug 2016 21:10:16 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Significant Support For Education And Research Regarding Wilson Disease</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12887g0io/*http://www.publicnow.com/view/F8F1EDC41C15A84BC4A4E7E085E78BDEBB97C894</link><description>[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced its commitment to improving the lives of Wilson disease patients around ...</description><guid isPermaLink="false">yahoo_finance/3729847845</guid><pubDate>Mon, 08 Aug 2016 21:10:16 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And Canada</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128he9i0b/*http://www.publicnow.com/view/0FB0D110D34FF0B5041B22D25EC8775160289A8A</link><description>[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today announced that it has entered into a licensing agreement ...</description><guid isPermaLink="false">yahoo_finance/711012682</guid><pubDate>Mon, 08 Aug 2016 12:18:05 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Changes To Executive Management Team</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128vm9ptp/*http://www.publicnow.com/view/8CAEED134A161936DAA5F9DEB6CF51A686E3C611</link><description>[at noodls] - Christina Ackermann Named Executive Vice President and General Counsel Scott Hirsch Joins Valeant as Senior Vice President, Business Strategy and Communications Senior Leaders Take on Expanded Roles; Executive ...</description><guid isPermaLink="false">yahoo_finance/1017003063</guid><pubDate>Mon, 08 Aug 2016 12:18:05 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286qm085/*http://www.publicnow.com/view/2A3F975B6C9B30C3306DF81DD1CC80A186F1F511</link><description>[at noodls] - LAVAL, Quebec, July 28, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve ...</description><guid isPermaLink="false">yahoo_finance/1878356206</guid><pubDate>Thu, 28 Jul 2016 21:28:04 GMT</pubDate></item><item><title>U.S. FDA panel backs Valeant psoriasis drug with risk program</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-194117169.html</link><description /><guid isPermaLink="false">yahoo_finance/546665029</guid><pubDate>Tue, 19 Jul 2016 20:22:17 GMT</pubDate></item><item><title>U.S. FDA panel backs Valeant psoriasis drug with risk management</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-192541935.html</link><description /><guid isPermaLink="false">yahoo_finance/3596236539</guid><pubDate>Tue, 19 Jul 2016 19:25:41 GMT</pubDate></item><item><title>Bad year for Wall Street's Golden Boy Ackman</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/bad-wall-streets-golden-boy-031523835.html</link><description /><guid isPermaLink="false">yahoo_finance/1788370195</guid><pubDate>Sun, 17 Jul 2016 03:15:23 GMT</pubDate></item><item><title>Bad year for Wall Street's Golden Boy Ackman</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/bad-wall-streets-golden-boy-021724403.html</link><description /><guid isPermaLink="false">yahoo_finance/330995388</guid><pubDate>Sun, 17 Jul 2016 02:17:24 GMT</pubDate></item><item><title>Bad year for Wall Street's Golden Boy Ackman</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://au.finance.yahoo.com/news/bad-wall-streets-golden-boy-171523532.html</link><description>[AFP] - For a Wall Street star once dubbed the "Baby Buffett," Bill Ackman is having a pretty bad year. Huge bets on companies like Valeant and Herbalife have delivered steep losses to the flamboyant billionaire's Pershing Square hedge fund. With some $12 billion under management, Pershing lost around 20 percent in the first half this year, securities filings show.</description><guid isPermaLink="false">yahoo_finance/3507043852</guid><pubDate>Sat, 16 Jul 2016 17:15:23 GMT</pubDate></item><item><title>Valeant psoriasis drug's suicide risk hard to assess -FDA Staff</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-psoriasis-drugs-suicide-risk-125928188.html</link><description /><guid isPermaLink="false">yahoo_finance/1898724493</guid><pubDate>Fri, 15 Jul 2016 13:30:59 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128hd0sm7/*http://www.publicnow.com/view/B07EB068DD46FE3EBDA1BCE61764CFA9143C9D80</link><description>[at noodls] - LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 ...</description><guid isPermaLink="false">yahoo_finance/2617432131</guid><pubDate>Fri, 15 Jul 2016 12:28:05 GMT</pubDate></item><item><title>Valeant psoriasis drug safety challenging to assess -FDA Staff</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-psoriasis-drug-safety-challenging-122601422.html</link><description /><guid isPermaLink="false">yahoo_finance/2406336331</guid><pubDate>Fri, 15 Jul 2016 12:26:01 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Comments On Recent Stock Transactions</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128pdbg8t/*http://www.publicnow.com/view/A1E981997F5F5F90CD074FA524F820C5C5D08096</link><description>[at noodls] - LAVAL, Quebec, July 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today commented on recent stock transactions made by Valeant's ...</description><guid isPermaLink="false">yahoo_finance/2044174105</guid><pubDate>Thu, 14 Jul 2016 13:28:07 GMT</pubDate></item><item><title>LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-chips-away-us-174142508.html</link><description /><guid isPermaLink="false">yahoo_finance/1468068438</guid><pubDate>Fri, 10 Jun 2016 17:41:42 GMT</pubDate></item><item><title>Valeant shares plunge after it slashes profit forecast</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-shares-plunge-slashes-profit-144515239.html</link><description /><guid isPermaLink="false">yahoo_finance/1905373350</guid><pubDate>Tue, 07 Jun 2016 14:45:15 GMT</pubDate></item><item><title>Valeant rejected joint takeover bid from Takeda, TPG in spring - source</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-rejected-joint-takeover-bid-033148516.html</link><description /><guid isPermaLink="false">yahoo_finance/2985257833</guid><pubDate>Fri, 27 May 2016 03:31:48 GMT</pubDate></item><item><title>Valeant appoints Tyco's Sam Eldessouky corporate controller</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-appoints-tycos-sam-eldessouky-112139669.html</link><description /><guid isPermaLink="false">yahoo_finance/3561268667</guid><pubDate>Thu, 26 May 2016 15:52:33 GMT</pubDate></item><item><title>Warren Buffett says more likely to buy IBM shares than sell - CNBC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/warren-buffett-says-more-likely-145701817.html</link><description /><guid isPermaLink="false">yahoo_finance/2811427456</guid><pubDate>Mon, 02 May 2016 19:27:59 GMT</pubDate></item></channel></rss>